{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:16:58Z","timestamp":1791944218415,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010438","name":"The Francis Crick Institute","doi-asserted-by":"publisher","award":["CC2223"],"award-info":[{"award-number":["CC2223"]}],"id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110110\/Z\/15\/Z"],"award-info":[{"award-number":["110110\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220549\/Z\/20\/Z"],"award-info":[{"award-number":["220549\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004789","name":"University of Oxford John Fell Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019418","name":"NIHR Maudsley Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019418","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jinf.2026.106682","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:05:22Z","timestamp":1767859522000},"page":"106682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Eligibility for hepatitis B virus (HBV) treatment and prevalence of drug resistance in a Ugandan population cohort"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6825-9324","authenticated-orcid":false,"given":"Sheila F.","family":"Lumley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Kimono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Mugisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Makanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses Kwizera","family":"Mbonye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Ojambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Waddilove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Ssengendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ndungutse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7436-8727","authenticated-orcid":false,"given":"Anna L.","family":"McNaughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence Nambaziira","family":"Muzaale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0583-5272","authenticated-orcid":false,"given":"Janet","family":"Seeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Quick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponsiano","family":"Ocama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-4269","authenticated-orcid":false,"given":"Philippa C.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jinf.2026.106682_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jinf.2026.106682_bib2","unstructured":"Global hepatitis report 2024: action for access in low- and middle-income countries [Internet]. World Health Organization; 2024 [cited 2024 Sep 30]. Available from: \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240091672\u3009."},{"key":"10.1016\/j.jinf.2026.106682_bib3","unstructured":"The global hepatitis health sector strategy \u2013 global targets. World Health Organization; 2017."},{"key":"10.1016\/j.jinf.2026.106682_bib4","unstructured":"Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030 [Internet] [cited 2024 Oct 3]. Available from: \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240053779\u3009."},{"key":"10.1016\/j.jinf.2026.106682_bib5","unstructured":"Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection [Internet]. World Health Organization; 2024 [cited 2024 Oct 3]. Available from: \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240090903\u3009."},{"key":"10.1016\/j.jinf.2026.106682_bib6","unstructured":"Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection [Internet]. World Health Organization; 2024 [cited 2024 Oct 3]. Available from: \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240090903\u3009."},{"issue":"1","key":"10.1016\/j.jinf.2026.106682_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s44263-023-00026-1","article-title":"A new approach to prevent, diagnose, and treat hepatitis B in Africa","volume":"1","author":"Spearman","year":"2023","journal-title":"BMC Glob Public Health"},{"issue":"3","key":"10.1016\/j.jinf.2026.106682_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41575-020-00398-x","article-title":"Extending treatment eligibility for chronic hepatitis B virus infection","volume":"18","author":"McNaughton","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jinf.2026.106682_bib9","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/S2214-109X(23)00467-9","article-title":"Treat all versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis","volume":"12","author":"Nguyen","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"11","key":"10.1016\/j.jinf.2026.106682_bib10","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jiph.2020.09.004","article-title":"A tool to measure the economic impact of hepatitis B elimination: a case study in Saudi Arabia","volume":"13","author":"Sanai","year":"2020","journal-title":"J Infect Public Health"},{"issue":"9","key":"10.1016\/j.jinf.2026.106682_bib11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/jvh.13843","article-title":"Cost-effectiveness of treating all hepatitis B-positive individuals in the United States","volume":"30","author":"Razavi-Shearer","year":"2023","journal-title":"J Viral Hepat"},{"issue":"4","key":"10.1016\/j.jinf.2026.106682_bib12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/apt.13488","article-title":"Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B","volume":"43","author":"Li","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jinf.2026.106682_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S2468-1253(23)00449-1","article-title":"Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study","volume":"9","author":"Minier","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jinf.2026.106682_bib14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jinf.2026.106682_bib15","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","article-title":"The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa","volume":"65","author":"Lemoine","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jinf.2026.106682_bib16","article-title":"A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir","volume":"174","author":"Lumley","year":"2024","journal-title":"J Clin Virol"},{"issue":"8","key":"10.1016\/j.jinf.2026.106682_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006629","article-title":"A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: a call for urgent action","volume":"12","author":"Mokaya","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jinf.2026.106682_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.12688\/wellcomeopenres.15992.1","article-title":"Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms","volume":"5","author":"Mokaya","year":"2020","journal-title":"Wellcome Open Res"},{"issue":"1","key":"10.1016\/j.jinf.2026.106682_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ije\/dys234","article-title":"The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies","volume":"42","author":"Asiki","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.jinf.2026.106682_bib20","article-title":"Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors","volume":"10","author":"O\u2019Hara","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jinf.2026.106682_bib21","unstructured":"Kimono B, Matthews P, Lumley S, Waddilove E, Mbonye MK, Makanga R, et al. Uganda liver disease study (ULiDS) - project summary 2023\u20132024 [Internet]. figshare; 2024. Available from: \u3008https:\/\/doi.org\/10.6084\/m9.figshare.25377379\u3009."},{"issue":"4","key":"10.1016\/j.jinf.2026.106682_bib22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/cid\/ciz916","article-title":"Risk factors for Kaposi\u2019s sarcoma-associated Herpesvirus DNA in blood and in saliva in rural Uganda","volume":"71","author":"Nalwoga","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2026.106682_bib23","unstructured":"Policy brief \u2013 guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection [Internet]. World Health Organization; 2024 [cited 2025 Jan 15]. Available from: \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240091368\u3009."},{"issue":"1","key":"10.1016\/j.jinf.2026.106682_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-022-35729-w","article-title":"Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa","volume":"14","author":"Johannessen","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jinf.2026.106682_bib25","unstructured":"Anderson M, Sukali G, Upton JL, Waddilove E, Downs L, Lumley S, et al. Elastography and cap assessment for liver disease: training events and feedback representing clinical research programmes in South Africa, Uganda and Kenya [Internet]. figshare; 2024. Available from: \u3008https:\/\/doi.org\/10.6084\/m9.figshare.27941958.v1\u3009."},{"key":"10.1016\/j.jinf.2026.106682_bib26","doi-asserted-by":"crossref","unstructured":"Lumley S, Quick J, Matthews P, Kent C. HEP-TILE: HBV whole genome sequencing (nanopore protocol); 2024 [cited 2024 Oct 2]; Available from: \u3008https:\/\/www.protocols.io\/view\/hep-tile-hbv-whole-genome-sequencing-nanopore-prot-5jyl82bedl2w\/v1\u3009.","DOI":"10.17504\/protocols.io.5jyl82bedl2w\/v1"},{"issue":"1","key":"10.1016\/j.jinf.2026.106682_bib27","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1038\/s41598-025-87721-1","article-title":"Whole genome sequencing of hepatitis B virus using tiled amplicon (HEPTILE) and probe based enrichment on Illumina and Nanopore platforms","volume":"15","author":"Lumley","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jinf.2026.106682_bib28","unstructured":"fieldbioinformatics: the ARTIC field bioinformatics pipeline [Internet]. Github [cited 2024 Oct 2]. Available from: \u3008https:\/\/github.com\/artic-network\/fieldbioinformatics\u3009."},{"key":"10.1016\/j.jinf.2026.106682_bib29","unstructured":"Genotyping [Internet] [cited 2024 Oct 2]. Available from: \u3008https:\/\/www.ncbi.nlm.nih.gov\/projects\/genotyping\/formpage.cgi\u3009."},{"key":"10.1016\/j.jinf.2026.106682_bib30","unstructured":"Geno2pheno hbv [Internet] [cited 2024 Oct 3]. Available from: \u3008https:\/\/hbv.geno2pheno.org\/index.php\u3009."},{"key":"10.1016\/j.jinf.2026.106682_bib31","unstructured":"The R project for statistical computing [Internet] [cited 2025 Jan 7]. Available from: \u3008https:\/\/www.R-project.org\/\u3009."},{"issue":"6","key":"10.1016\/j.jinf.2026.106682_bib32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S2468-1253(24)00089-X","article-title":"WHO 2024 hepatitis B guidelines: an opportunity to transform care","volume":"9","author":"Easterbrook","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445326000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445326000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:34:28Z","timestamp":1781771668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445326000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0163445326000071"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106682","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eligibility for hepatitis B virus (HBV) treatment and prevalence of drug resistance in a Ugandan population cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106682"}}